Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Cancer Screening Outreach Guided by Machine Learning: The Benefits of Proactive Care
0
Zitationen
6
Autoren
2026
Jahr
Abstract
Problem definition: With the advance of data analytics, many disease prediction models have been developed with the intent of detecting diseases earlier and improving patient outcomes through earlier treatment. The operationalization of interventions and care based on these predictive models is critical to attaining these goals. We study the real-world effects of a machine learning-guided colorectal cancer screening outreach program deployed at a health system in Pennsylvania. Methodology/results: Using a regression discontinuity design based on the predicted risk score for having cancer, we find that the program increases the likelihood of colonoscopy uptake in three and six months by 6.0 percentage points (214% increase relative to the control sample within the bandwidth) and 6.9 percentage points (117% increase), respectively. Importantly, we also find significant effects on mortality. We estimate that the program decreases two-year mortality by 6.2 percentage points (43% decrease). Managerial implications: Our finding suggests that a proactive cancer screening outreach program where individuals are selected for intervention based on a machine learning algorithm could significantly improve patient outcomes in addition to achieving higher disease detection rates. Our analysis demonstrates an analytical framework for rigorously evaluating machine learning-aided outreach programs for other cancers and diseases. Establishing unbiased estimates of the impact of machine learning-aided screening outreach is critical for capacity planning of screening resources, such as colonoscopies. History: This paper has been accepted as part of the 2025 Manufacturing & Service Operations Management Practice-Based Research Competition. Supplemental Material: The online appendix is available at https://doi.org/10.1287/msom.2024.1353 .
Ähnliche Arbeiten
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 · 111.034 Zit.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 · 87.423 Zit.
Global cancer statistics
2011 · 55.016 Zit.
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2014 · 28.979 Zit.
Global cancer statistics, 2012
2015 · 27.327 Zit.